ONCOLOGÍA CELULAR
![Foto de ONCOLOGÍA CELULAR](/img/grupo.png)
![Foto de Hospital Miguel Servet](/img/noimage_org.png)
Hospital Miguel Servet
Zaragoza, EspañaPublications en collaboration avec des chercheurs de Hospital Miguel Servet (2)
2017
-
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681
-
Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
European Journal of Cancer, Vol. 75, pp. 73-82